Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DICLOXACILLIN 250 MG CAPSULE

Dicloxacillin Sodium
$0.5607per EA

Strength

250 mg/1

Manufacturer

Teva Pharmaceuticals USA Inc.

NDC

00093312301

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DICLOXACILLIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA062286

On Market Since

9/30/1990

Pharmacological Classes

Penicillin-class Antibacterial
Penicillins

Price History

1W

0.0%

1M

+3.4%

3M

+0.4%

6M

-6.4%

1Y

+32.6%

3Y

+23.3%

5Y

+14.7%

All

+158.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

AMOXICILLIN 125 MG/5 ML SUSP
Generic
00143988815•Hikma Pharmaceuticals USA Inc.
$0.0188
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00781603955•Sandoz Inc.
$0.0188
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
65862070655•Aurobindo Pharma Limited
$0.0188
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00143988801•Hikma Pharmaceuticals USA Inc.
$0.0204
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00781603946•Sandoz Inc.
$0.0204
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
65862070601•Aurobindo Pharma Limited
$0.0204
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00143988880•Hikma Pharmaceuticals USA Inc.
$0.0227
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
00781603958•Sandoz Inc.
$0.0227
per ML
AMOXICILLIN 125 MG/5 ML SUSP
Generic
65862070680•Aurobindo Pharma Limited
$0.0227
per ML
AMOXICILLIN 250 MG/5 ML SUSP
Generic
00093415573•Teva Pharmaceuticals USA Inc.
$0.0246
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy